Clinical Trials · NCT00003283
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Enrollment
- 38
- Start date
- Oct 1998
- Locations
- 25 sites, United States, South Africa
- Primary endpoint
- Study in Thymoma and Thymic Carcinoma